181 related articles for article (PubMed ID: 8316826)
1. Scripps backs down on controversial Sandoz deal.
Anderson C
Science; 1993 Jun; 260(5116):1872-3. PubMed ID: 8316826
[No Abstract] [Full Text] [Related]
2. Health chief assails a research deal.
Hilts PJ
N Y Times Web; 1993 Mar; ():A12. PubMed ID: 11646979
[No Abstract] [Full Text] [Related]
3. Washington perspective: science's leading congressional critic strikes again.
Greenberg DS
Lancet; 1991 Mar; 337(8742):665-6. PubMed ID: 11642971
[No Abstract] [Full Text] [Related]
4. Conflict-of-interest debate stirs mixed reaction at NIH.
Macilwain C
Nature; 1994 Feb; 367(6462):401. PubMed ID: 8107786
[No Abstract] [Full Text] [Related]
5. New charges hit Illmensee.
MacKenzie D
New Sci; 1984 May; 102(1412):3-4. PubMed ID: 11655608
[No Abstract] [Full Text] [Related]
6. Federal inquiry finds misconduct by a discoverer of the AIDS virus.
Hilts P
N Y Times Web; 1992 Dec; ():A1, A20. PubMed ID: 11646949
[No Abstract] [Full Text] [Related]
7. Scripps to get less from Sandoz.
Anderson C
Science; 1994 May; 264(5162):1077. PubMed ID: 8178164
[No Abstract] [Full Text] [Related]
8. Corporate responsibility for recombinant DNA activities.
Berger BA
Univ Toledo Law Rev; 1981; 12(4):913-24. PubMed ID: 11649592
[No Abstract] [Full Text] [Related]
9. Proposal for a coordinated framework for regulation of biotechnology.
U.S. Office of Science and Technology Policy
Fed Regist; 1984 Dec; 49(252):50856-907. PubMed ID: 11655658
[No Abstract] [Full Text] [Related]
10. Recombinant DNA research; proposed actions under guidelines; notices.
U.S. National Institutes of Health
Fed Regist; 1988 Sep; 53(171):34246-7. PubMed ID: 11655893
[No Abstract] [Full Text] [Related]
11. Terms of Scripps-Sandoz agreement may be more common than its critics believe.
Mervis J
Nature; 1993 Mar; 362(6417):194-5. PubMed ID: 8459840
[No Abstract] [Full Text] [Related]
12. Coordinated framework for regulation of biotechnology; establishment of the Biotechnology Science Coordinating Committee; notice.
U.S. Office of Science and Technology Policy
Fed Regist; 1985 Nov; 50(220):47174-95. PubMed ID: 11655733
[No Abstract] [Full Text] [Related]
13. Recombinant DNA and the law: review of some general legal considerations.
Korwek EL
Gene; 1981; 15():1-5. PubMed ID: 11658461
[No Abstract] [Full Text] [Related]
14. Science friction.
Gladwell M
Washington Post; 1992 Dec; ():18-21, 49-51. PubMed ID: 11646256
[No Abstract] [Full Text] [Related]
15. Trouble in the laboratory: probing the science of a controversial paper.
Fackelmann KA
Sci News; 1990 Mar; 137(13):200-203, 205. PubMed ID: 11650334
[No Abstract] [Full Text] [Related]
16. U.S. inquiry on misconduct in discovery of AIDS virus.
Hilts PJ
N Y Times Web; 1990 Oct; ():1, 6. PubMed ID: 11646783
[No Abstract] [Full Text] [Related]
17. Conduct unbecoming?
Weiss P
N Y Times Mag; 1989 Oct; ():40-41, 68-69, 95. PubMed ID: 11650263
[No Abstract] [Full Text] [Related]
18. 'Verdicts' are in on the Gallo probe.
Palca J
Science; 1992 May; 256(5058):735-8. PubMed ID: 1589751
[No Abstract] [Full Text] [Related]
19. Development of vaccines to meet public health needs: incentives and obstacles.
Russell PK
Risk; 1996; 7(3):239-52. PubMed ID: 11655077
[No Abstract] [Full Text] [Related]
20. Fraudbusters back at NIH.
Culliton BJ
Science; 1990 Jun; 48(4963):1599. PubMed ID: 11653895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
